Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Collegium Pharma (COLL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 880,846
  • Shares Outstanding, K 33,040
  • Annual Sales, $ 28,480 K
  • Annual Income, $ -74,870 K
  • 36-Month Beta 0.73
  • Price/Sales 30.97
  • Price/Cash Flow N/A
  • Price/Book 9.62

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.07 +28.18%
on 05/31/18
28.91 -2.14%
on 06/20/18
+2.57 (+9.99%)
since 05/18/18
3-Month
20.81 +35.94%
on 04/06/18
28.91 -2.14%
on 06/20/18
+1.89 (+7.16%)
since 03/20/18
52-Week
9.01 +213.98%
on 10/31/17
29.90 -5.38%
on 03/09/18
+17.02 (+151.02%)
since 06/20/17

Most Recent Stories

More News
New Research: Key Drivers of Growth for Outfront Media, Enel Chile, Banc of California, Northern Dynasty Minerals, Collegium Pharmaceutical, and Petroleo Brasileiro S.A. - Petrobras -- Factors of Influence, Major Initiatives and Sustained Production

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Outfront Media Inc. (NYSE:OUT),...

PBR-A : N/A (unch)
ENIC : 5.13 (-1.54%)
COLL : 28.29 (+6.11%)
NAK : 0.51 (+3.27%)
BANC : 19.60 (unch)
OUT : 19.95 (+1.42%)
Ocular Therapeut is Among the Companies in the Pharmaceuticals Industry with the Best Relative Performance (OCUL , ENDP , COLL , OMER , AKRX )

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look...

COLL : 28.29 (+6.11%)
ENDP : 9.43 (-0.11%)
OCUL : 7.91 (-1.37%)
Collegium Announces CEO Succession

Joseph Ciaffoni Promoted to CEO and Appointed to Board

COLL : 28.29 (+6.11%)
Top 5 Companies in the Pharmaceuticals Industry with the Best Relative Performance (NKTR , COLL , AERI , MDCO , RVNC )

Here are the top 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

COLL : 28.29 (+6.11%)
AERI : 65.90 (+1.70%)
NKTR : 58.17 (+1.41%)
Nektar (NKTR) Seeks Approval for Analgesic Opioid Candidate

Nektar (NKTR) submits NDA to the FDA seeking approval of its analgesic opioid candidate, NKTR-181, for the treatment of chronic low back pain.

COLL : 28.29 (+6.11%)
TEVA : 24.28 (+0.96%)
BMY : 54.25 (+1.14%)
NKTR : 58.17 (+1.41%)
Collegium to Present at Upcoming Investor Conferences

Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that management will present at the following investor conferences in June:

COLL : 28.29 (+6.11%)
Prestige Brands is Among the Companies in the Pharmaceuticals Industry with the Best Relative Performance (PBH , DEPO , COLL , LCI , AKRX )

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look...

COLL : 28.29 (+6.11%)
PBH : 37.89 (+1.72%)
DEPO : 7.35 (+1.80%)
Collegium Reports First Quarter Financial Results and Provides Corporate Update

-- Xtampza ER prescriptions grew by 72% in the first quarter

COLL : 28.29 (+6.11%)
What's in Store for Penumbra (PEN) This Earnings Season?

Penumbra (PEN) deepens its focus on driving innovation, ramping up production and expanding geographies.

MGNX : 23.51 (+2.44%)
COLL : 28.29 (+6.11%)
ARRY : 19.99 (+5.21%)
PEN : 154.60 (+0.82%)
Investor Expectations to Drive Momentum within WESCO International, Microchip Technology, Collegium Pharmaceutical, Actuant, Toro, and Expeditors International of Washington -- Discovering Underlying Factors of Influence

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of WESCO International, Inc. (NYSE:WCC),...

ATU : 29.05 (+11.95%)
TTC : 60.74 (+0.07%)
COLL : 28.29 (+6.11%)
WCC : 60.40 (-2.34%)
EXPD : 75.04 (+0.55%)
MCHP : 101.23 (+0.83%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy and ranks in the Top 1% of all short term signal directions.

Longer term, the trend strength is Maximum. Long term indicators mostly agree with the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade COLL with:

Business Summary

Collegium Pharmaceutical Inc. is a specialty pharmaceutical company. It develops and commercializes prescription and over-the-counter pharmaceuticals for the treatment of central nervous system, respiratory and skin related disorders. The Company's product candidate consists of COL-195, COL-196, COL-171,...

See More

Key Turning Points

2nd Resistance Point 30.20
1st Resistance Point 29.25
Last Price 28.29
1st Support Level 27.00
2nd Support Level 25.70

See More

52-Week High 29.90
Last Price 28.29
Fibonacci 61.8% 21.92
Fibonacci 50% 19.45
Fibonacci 38.2% 16.99
52-Week Low 9.01

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar